Judith Diane Ferguson - Comment

Document ID: FDA-2012-N-0548-0087
Document Type: Public Submission
Agency: Food And Drug Administration
Received Date: December 28 2012, at 12:00 AM Eastern Standard Time
Date Posted: January 3 2013, at 12:00 AM Eastern Standard Time
Comment Start Date: December 19 2012, at 12:00 AM Eastern Standard Time
Comment Due Date: January 9 2013, at 11:59 PM Eastern Standard Time
Tracking Number: 1jw-82sn-sseg
View Document:  View as format xml

View Comment

I am objecting to changing this drug from class 3 to class 2. There are a majority of people who do not get easily addicted to this type of drug and do not abuse it. Most people do not abuse. Please do not do this to those that really need good access to the drug that are chronically ill like me.

Related Comments

    View All
Total: 399
ken b cairns - Comment
Public Submission    Posted: 01/04/2013     ID: FDA-2012-N-0548-0093

Jan 09,2013 11:59 PM ET
Mark Terry Sokolow - Comment
Public Submission    Posted: 01/07/2013     ID: FDA-2012-N-0548-0094

Jan 09,2013 11:59 PM ET
elise kaplan - Comment
Public Submission    Posted: 01/04/2013     ID: FDA-2012-N-0548-0090

Jan 09,2013 11:59 PM ET
Judith Diane Ferguson - Comment
Public Submission    Posted: 01/03/2013     ID: FDA-2012-N-0548-0087

Jan 09,2013 11:59 PM ET
Advocates for the Reform of Prescription Opioids, Inc. (ARPO) - Comment
Public Submission    Posted: 01/03/2013     ID: FDA-2012-N-0548-0089

Jan 09,2013 11:59 PM ET